Cengild Medical BhdXKLS:0243 67 Market Cap is RM166.58 Mil as of Jul. 02, 2026. GuruFocus rates XKLS:0243 with a GF Score™ of 67/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Cengild Medical Bhd ranks worse than 64.89% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cengild Medical Bhd's share price for the quarter that ended in Mar. 2026 was RM0.21. Cengild Medical Bhd's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 832.91 Mil. Therefore, Cengild Medical Bhd's market cap for the quarter that ended in Mar. 2026 was RM174.91 Mil.
Cengild Medical Bhd's quarterly market cap
declined
from Sep. 2025 (RM199.90 Mil) to Dec. 2025 (RM187.41 Mil) and
declined
from Dec. 2025 (RM187.41 Mil) to Mar. 2026 (RM174.91 Mil).
Cengild Medical Bhd's annual market cap
declined
from Jun. 2023 (RM328.99 Mil) to Jun. 2024 (RM262.37 Mil) and
declined
from Jun. 2024 (RM262.37 Mil) to Jun. 2025 (RM191.57 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cengild Medical Bhd's Enterprise Value for Today is RM197.73 Mil.
Cengild Medical Bhd (XKLS:0243) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cengild Medical Bhd Market Cap Related Terms
Cengild Medical Bhd Market Cap Historical Data
* Premium members only.
The historical data trend for Cengild Medical Bhd's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cengild Medical Bhd's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cengild Medical Bhd Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's Market Cap distribution charts can be found below:
* The bar in red indicates where Cengild Medical Bhd's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cengild Medical Bhd's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cengild Medical Bhd (XKLS:0243) has a Market Cap of RM166.58 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cengild Medical Bhd and its competitors. According to the industry distribution chart, Cengild Medical Bhd ranks #451 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 64.9%.
Is Cengild Medical Bhd's Market Cap too high?
Cengild Medical Bhd's current Market Cap is RM166.58 Mil. Based on the distribution chart, Cengild Medical Bhd ranks #451 out of 695 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Cengild Medical Bhd has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cengild Medical Bhd ranks #451 out of 695 companies for Market Cap. This places Cengild Medical Bhd in the lower half of its industry. The industry median Market Cap is 96.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 96.57, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cengild Medical Bhd and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 96.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cengild Medical Bhd's current Market Cap is RM166.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.20 — trading 31% below its estimated fair value. The current Market Cap is RM166.58 Mil. Cengild Medical Bhd's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current Market Cap is RM166.58 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.20 is trading 31% below its estimated GF Value™ of RM0.29.
GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0243:
Market Cap: RM166.58 Mil
GF Value™: RM0.29 vs. price of RM0.20 (31% below fair value)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
67GF Score
Get the complete analysis for XKLS:0243
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
